Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.
Valink Therapeutics has raised $11.8M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Valink Therapeutics's investors include Y Combinator, Hoxton Ventures, Oxford Science Enterprises, redalpine, Oxonian Ventures.
Valink Therapeutics is headquartered in London, United Kingdom.
Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.
Valink Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Valink Therapeutics — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/valink-therapeutics. Accessed August 1, 2026.
VCBacked. (2025). Valink Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/valink-therapeutics
{{cite web |title=Valink Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/valink-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated